Do we still need breast cancer screening in the era of targeted therapies and precision medicine?

Breast cancer (BC) is the most common female cancer and the second cause of death among women worldwide. The 5-year relative survival rate recently improved up to 90% due to increased population coverage and women’s attendance to organised mammography screening as well as to advances in therapies, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Trimboli, Rubina Manuela, Giorgi Rossi, Paolo, Battisti, Nicolò Matteo Luca, Cozzi, Andrea, Magni, Veronica, Zanardo, Moreno, Sardanelli, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Critical Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519022/
https://www.ncbi.nlm.nih.gov/pubmed/32975658
http://dx.doi.org/10.1186/s13244-020-00905-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519022/
https://www.ncbi.nlm.nih.gov/pubmed/32975658
http://dx.doi.org/10.1186/s13244-020-00905-3

Ejemplares similares